Rocket Secures Credit Facility From Hercules Capital
MT newswire2026/10/06 20:4804:48 PM EDT, 10/06/2026 (MT Newswires) -- Rocket Pharmaceuticals (RCKT) said late Tuesday it has entered into a credit facility agreement with Hercules Capital (HTGC) for up to $150 million, including $35 million at closing. The facility has an initial 30-month interest-only period and a 48-month maturity, with extensions available upon achievement of specified milestones, the firm said, adding that the financing also includes warrants to purchase Rocket shares. The facility will strengthen its financial position and help support its phase 2 study of RP-A501 in Danon disease and advance its broader cardiovascular pipeline, the company said.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
